The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Merck Sharp & Dohme Corp. since 2018.
The trader's CIK number is 942443.
At the time of the last reporting, Merck Sharp & Dohme Corp. was the 10% Owner of Ngm Biopharmaceuticals Inc. (stock ticker symbol NGM).
Also see all insider trading activities at Ngm Biopharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | STRO | 666,666 | $9,999,990 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | NGM | 4,121,683 | $65,946,928 | 0 | $0 | 0 | $0 |
1. Sutro Biopharma, Inc. (STRO)
2. Ngm Biopharmaceuticals Inc (NGM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-01 | STRO | Buy | 666,666 | 15.00 | 9,999,990 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-04-08 | NGM | Buy | 4,121,683 | 16.00 | 65,946,928 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Merck Sharp & Dohme Corp. (10% Owner of Ngm Biopharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.